Israel Englander Accelerate Diagnostics, Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.64 - $1.03 $303,253 - $488,047	-473,833 Reduced 79.37%	123,141 $99,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.77 $73,365 - $122,808	-159,491 Reduced 21.08%	596,974 $418,000
Q4 2022 Feb 14, 2023	SELL	$0.51 - $17.1 $102,146 - $3.42 Million	-200,288 Reduced 20.93%	756,465 $534,000
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $726,156 - $12.2 Million	718,967 Added 302.36%	956,753 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $109,454 - $285,798	-202,694 Reduced 46.02%	237,786 $236,000
Q1 2022 May 16, 2022	BUY	$1.4 - $5.15 $187,444 - $689,528	133,889 Added 43.67%	440,480 $634,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $350,174 - $571,595	82,008 Added 36.52%	306,591 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $954,668 - $1.48 Million	179,787 Added 401.35%	224,583 $1.31 Million
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.23 $192,062 - $260,313	-28,203 Reduced 38.63%	44,796 $361,000
Q1 2021 May 17, 2021	BUY	$7.99 - $15.0 $361,923 - $679,455	45,297 Added 163.52%	72,999 $607,000
Q4 2020 Feb 16, 2021	BUY	$7.04 - $11.7 $25,280 - $42,014	3,591 Added 14.89%	27,702 $210,000
Q3 2020 Nov 16, 2020	BUY	$9.98 - $18.04 $6,606 - $11,942	662 Added 2.82%	24,111 $257,000
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $18,110 - $36,656	-2,418 Reduced 9.35%	23,449 $355,000
Q1 2020 May 14, 2020	BUY	$4.62 - $18.74 $119,505 - $484,747	25,867 New	25,867 $215,000
Q3 2019 Nov 14, 2019	SELL	$16.62 - $23.92 $186,775 - $268,812	-11,238 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.79 - $22.88 $199,924 - $257,125	11,238 New	11,238 $257,000

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account